PharmD_Rodriguez said:

I want to bring up the cardiovascular angle on cardiovascular risk.

Adding a me-too, because a thread of one person's experience is not much use. I had assumed I was the exception until I read this.

BethLabQueen said:

Senior perspective on cardiovascular risk: I'm 70 years old and started this journey skeptically.

BethLabQueen said:

...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

BethLabQueen said:

Senior perspective on cardiovascular risk: I'm 70 years old and started this journey skeptically.

Mendelian randomization evidence supporting GLP-1 pathway modulation for cardiovascular risk: genetic variants in the GLP1R gene region associated with lower BMI also show associations with reduced cardiovascular risk, confirming a causal pathway[1].

This "natural experiment" (people born with genetically higher GLP-1 signaling being leaner and healthier) provides orthogonal evidence supporting the pharmacological approach. When genetic epidemiology, clinical trials, and mechanistic studies all converge, confidence in the therapeutic approach is high.

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.